drugset / Trial / NCT00427882
Male Sexual Health Questionnaire (MSHQ) - Sexual Function Study
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Primary: To assess improvement in ejaculation from baseline to the end of treatment (Week 12 or premature withdrawal) with Alfuzosin 10mg OD, using MSHQ score. Secondary: * To evaluate sexual function improvement * To evaluate LUTS (Lower Uninary Tract Symptoms) improvement * To evaluate the association between LUTS severity and sexual function. * To assess the safety and the tolerability of Alfuzosin 10mg OD.
Timeline
- Start
- 2006-09
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alfuzosin | Small molecule | 10 mg | — |